Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Verzijlbergen, J"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial.
    Autorzy:
    Janssen J; Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, Postbus 30 001, 9700 RB, Groningen, the Netherlands. j..
    Staal FHE; Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, Postbus 30 001, 9700 RB, Groningen, the Netherlands.
    Brouwer CL; Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, Postbus 30 001, 9700 RB, Groningen, the Netherlands.
    Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, Postbus 30 001, 9700 RB, Groningen, the Netherlands.
    de Jong IJ; Department of Urology, University Medical Center Groningen, Groningen, the Netherlands.
    van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
    Schuit E; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
    Verzijlbergen JF; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
    Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
    Aluwini S; Department of Radiation Oncology, University Medical Center Groningen, Hanzeplein 1, Postbus 30 001, 9700 RB, Groningen, the Netherlands.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2022 May 02; Vol. 22 (1), pp. 482. Date of Electronic Publication: 2022 May 02.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Prostatic Neoplasms*/drug therapy
    Prostatic Neoplasms*/radiotherapy
    Androgen Antagonists/therapeutic use ; Androgens ; Chronic Disease ; Clinical Trials, Phase III as Topic ; Humans ; Male ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Positron Emission Tomography Computed Tomography ; Quality of Life ; Randomized Controlled Trials as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol.
    Autorzy:
    Staal FHE; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands. .
    Janssen J; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
    Brouwer CL; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
    Langendijk JA; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
    Ng Wei Siang K; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
    Schuit E; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
    de Jong IJ; Department of Urology, University Medical Centre Groningen, Groningen, The Netherlands.
    Verzijlbergen JF; Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
    Smeenk RJ; Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
    Aluwini S; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2022 Apr 15; Vol. 22 (1), pp. 416. Date of Electronic Publication: 2022 Apr 15.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Positron Emission Tomography Computed Tomography*/methods
    Prostatic Neoplasms*/diagnostic imaging
    Prostatic Neoplasms*/radiotherapy
    Prostatic Neoplasms*/surgery
    Clinical Trials, Phase III as Topic ; Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Multicenter Studies as Topic ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Prospective Studies ; Prostate/pathology ; Prostate-Specific Antigen ; Prostatectomy/methods ; Quality of Life ; Radiation Dose Hypofractionation ; Randomized Controlled Trials as Topic ; Salvage Therapy/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
    Autorzy:
    Privé BM; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Janssen MJR; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    van Oort IM; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
    Muselaers CHJ; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
    Jonker MA; Department of Health Evidence, Radboudumc, Nijmegen, The Netherlands.
    van Gemert WA; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    de Groot M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Westdorp H; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
    Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
    Verzijlbergen JF; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Zámecnik P; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Barentsz JO; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Gotthardt M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Noordzij W; Department of Radiology and Nuclear Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
    Vogel WV; Department of Radiology and Nuclear Medicine, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Radiation Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Bergman AM; Department of Medical Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    van der Poel HG; Department of Urology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Vis AN; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
    Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
    Gerritsen WR; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
    Witjes JA; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
    Nagarajah J; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands. .
    Pokaż więcej
    Źródło:
    Trials [Trials] 2021 Nov 04; Vol. 22 (1), pp. 768. Date of Electronic Publication: 2021 Nov 04.
    Typ publikacji:
    Letter; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Androgen Antagonists*
    Prostatic Neoplasms, Castration-Resistant*/diagnostic imaging
    Prostatic Neoplasms, Castration-Resistant*/drug therapy
    Hormones ; Humans ; Lutetium/adverse effects ; Male ; Radioisotopes
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.
    Autorzy:
    Privé BM; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Janssen MJR; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    van Oort IM; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
    Muselaers CHJ; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
    Jonker MA; Department of Health Evidence, Radboudumc, Nijmegen, The Netherlands.
    de Groot M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Mehra N; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
    Verzijlbergen JF; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Zámecnik P; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Barentsz JO; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Gotthardt M; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands.
    Noordzij W; Department of Radiology and Nuclear Medicine, University Medical Center Groningen, Groningen, The Netherlands.
    Vogel WV; Department of Radiology and Nuclear Medicine, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Radiation Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Bergman AM; Department of Medical Oncology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    van der Poel HG; Department of Urology, NKI Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Vis AN; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
    Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
    Gerritsen WR; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.
    Witjes JA; Department of Urology, Radboudumc, Nijmegen, The Netherlands.
    Nagarajah J; Department of Radiology and Nuclear Medicine, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, The Netherlands. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2020 Sep 14; Vol. 20 (1), pp. 884. Date of Electronic Publication: 2020 Sep 14.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Lutetium/*administration & dosage
    Neoplasms, Hormone-Dependent/*drug therapy
    Prostatic Neoplasms/*drug therapy
    Prostatic Neoplasms, Castration-Resistant/*drug therapy
    Radioisotopes/*administration & dosage
    Androgen Antagonists/administration & dosage ; Androgen Antagonists/adverse effects ; Disease Progression ; Hormones/genetics ; Hormones/metabolism ; Humans ; Lutetium/adverse effects ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasms, Hormone-Dependent/pathology ; Neoplasms, Hormone-Dependent/radiotherapy ; Progression-Free Survival ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Prostatic Neoplasms, Castration-Resistant/radiotherapy ; Quality of Life ; Radioisotopes/adverse effects ; Radiopharmaceuticals/administration & dosage ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Low-dose single acquisition rest (99m)Tc/stress (201)Tl myocardial perfusion SPECT protocol: phantom studies and clinical validation.
    Autorzy:
    Dey T; Institute of Imaging & Computer Vision, RWTH Aachen University, Aachen, Germany, .
    Backus BE
    Romijn RL
    Wieczorek H
    Verzijlbergen JF
    Pokaż więcej
    Źródło:
    European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2014 Mar; Vol. 41 (3), pp. 536-47. Date of Electronic Publication: 2013 Sep 13.
    Typ publikacji:
    Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
    MeSH Terms:
    Radiopharmaceuticals*/pharmacokinetics
    Technetium Tc 99m Sestamibi*/pharmacokinetics
    Thallium*/pharmacokinetics
    Exercise Test/*methods
    Myocardial Perfusion Imaging/*methods
    Tomography, Emission-Computed, Single-Photon/*methods
    Adult ; Aged ; Aged, 80 and over ; Coronary Artery Disease/diagnostic imaging ; Female ; Humans ; Male ; Middle Aged ; Phantoms, Imaging
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Effects of pacing rates on global and regional myocardial blood flow.
    Autorzy:
    Ten Cate TJ; Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands. />Knaapen P
    Lammertsma AA
    De Cock CC
    Van Hemel NM
    Verzijlbergen JF
    Pokaż więcej
    Źródło:
    Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2011 May; Vol. 34 (5), pp. 587-92.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Positron-Emission Tomography*
    Cardiac Pacing, Artificial/*methods
    Coronary Circulation/*physiology
    Regional Blood Flow/*physiology
    Sick Sinus Syndrome/*diagnostic imaging
    Sick Sinus Syndrome/*therapy
    Aged ; Analysis of Variance ; Female ; Humans ; Male ; Regression Analysis ; Sick Sinus Syndrome/physiopathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Incremental prognostic value of myocardial SPET with dual-isotope rest (201)Tl/stress (99m)Tc-tetrofosmin.
    Autorzy:
    Groutars RG; Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.
    Verzijlbergen JF
    Zwinderman AH
    Tiel-Van Buul MM
    Ascoop CA
    van Hemel NM
    van der Wall EE
    Pokaż więcej
    Źródło:
    European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2002 Jan; Vol. 29 (1), pp. 46-52. Date of Electronic Publication: 2001 Oct 25.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Exercise Test*
    Organophosphorus Compounds*
    Organotechnetium Compounds*
    Radiopharmaceuticals*
    Thallium Radioisotopes*
    Tomography, Emission-Computed, Single-Photon*
    Coronary Disease/*diagnostic imaging
    Adult ; Aged ; Aged, 80 and over ; Coronary Disease/diagnosis ; Coronary Disease/mortality ; Electrocardiography ; Female ; Heart/diagnostic imaging ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Proportional Hazards Models ; Survival Analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies